Lien H. Do

Flemington Road
Parkville, VIC 3051, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Targeted pneumococcal conjugate vaccination strategies for high-risk children.

Targeted pneumococcal conjugate vaccination strategies for high-risk children.

Journal: Human vaccines & immunotherapeutics

Published: June 03, 2026

Reply to Ma et al. Comments on our Article 10.1093/infdis/jiaf177.

Reply to Ma et al. Comments on our Article 10.1093/infdis/jiaf177.

Journal: The Journal of infectious diseases

Published: March 07, 2026

Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial.

Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial.

Journal: Frontiers in immunology

Published: January 16, 2026

Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.

Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.

Journal: Vaccine

Published: January 08, 2026

Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults.

Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults.

Journal: Frontiers in immunology

Published: January 02, 2026

High vulnerability of infants under 6 months of age in Vietnam's measles outbreak.

High vulnerability of infants under 6 months of age in Vietnam's measles outbreak.

Journal: Vaccine

Published: November 14, 2025

Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia.

Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia.

Journal: The Journal of infection

Published: November 11, 2025

Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019-2022).

Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019-2022).

Journal: Pneumonia (Nathan Qld.)

Published: June 28, 2025

Measles 2025.

Measles 2025.

Journal: The New England journal of medicine

Published: June 25, 2025

Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial.

Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial.

Journal: Vaccine

Published: February 18, 2025

Measles Seroprevalence in Infants Under 9 Months of Age in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

Measles Seroprevalence in Infants Under 9 Months of Age in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

Journal: The Journal of infectious diseases

Published: January 22, 2025

The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.

The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.

Journal: The Journal of infection

Published: November 07, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026